MTOR and cancer: Control of protein synthesis is commonly dysregulated in cancer, most frequently by mutational activation of the phosphoinositide 3-kinase, protein kinase B/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway.